Nutramax Laboratories, Inc.
Records under this name other than the patents Nutramax Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.
Back to Nutramax Laboratories, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,808,770 | Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals Term ended Term ended Apr 30, 2026 · From the USPTO record | Term ended | Term ended Apr 30, 2026 | From the USPTO record |
| US 9,572,791 | Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals Term ended Term ended Apr 1, 2026 · From the USPTO record | Term ended | Term ended Apr 1, 2026 | From the USPTO record |
| US 10,456,372 | Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals Term ended Ended no later than Jul 29, 2025 · From the USPTO record | Term ended | Ended no later than Jul 29, 2025 | From the USPTO record |
| US 10,780,077 | Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals Term ended Ended no later than Jul 29, 2025 · From the USPTO record | Term ended | Ended no later than Jul 29, 2025 | From the USPTO record |
| US 11,419,848 | Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals Term ended Ended no later than Jul 29, 2025 · From the USPTO record | Term ended | Ended no later than Jul 29, 2025 | From the USPTO record |
| US 8,568,803 | Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals Term ended Term ended Jul 19, 2021 · From the USPTO record | Term ended | Term ended Jul 19, 2021 | From the USPTO record |
| US 8,753,697 | Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals Term ended Term ended Mar 6, 2021 · From the USPTO record | Term ended | Term ended Mar 6, 2021 | From the USPTO record |
| US 7,563,779 | L-ergothioneine, milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage Term ended Term ended Nov 16, 2020 · From the USPTO record | Term ended | Term ended Nov 16, 2020 | From the USPTO record |
| US 8,846,118 | Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals Term ended Term ended Oct 19, 2020 · From the USPTO record | Term ended | Term ended Oct 19, 2020 | From the USPTO record |
| US 6,863,906 | L-ergothioneine, milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage Term ended Term ended Sep 25, 2019 · From the USPTO record | Term ended | Term ended Sep 25, 2019 | From the USPTO record |